Twist launches synthetic RNA capsules

By The Science Advisory Board staff writers

March 22, 2022 -- Twist Bioscience has launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in proprietary stainless steel minicapsules provided by Imagene SA.

The design enables enhanced storage and transportation and cost-efficiency. The synthetic controls, which are designed based on specific SARS-CoV-2 variants, cover the full viral genome and are sequence-verified.

Imagene stainless steel minicapsule. Image courtesy of Imagene.

Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.